Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment
Rachel Goldstein, Aviya R. Jacobs, Lana Zighan, Naomi Gronich, Meir Bialer, Mordechai Muszkat
Topics & Concepts
PharmacologyRivaroxabanApixabanPharmacokineticsMedicineCYP2C9RifampicinCYP2D6Cytochrome P450WarfarinAtrial fibrillationInternal medicineMetabolismPathologyTuberculosisAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementBlood Pressure and Hypertension Studies